Department of Drug Design and Pharmacology

Personalised Medicine Research Cluster

Scientific mission

Moving beyond the one-size-fits-all treatment approach
Providing better health for all, one patient at a time
Ensuring safe and effective treatment for the individual patient

Research groups

Highlights

Lotte Stig Nørgaard has joined the Personalised Medicine cluster
Alexander Hauser receives Bayer Pharmaceuticals PhD Award
Utilizing drug-target-event relationships to unveil safety patterns in pharmacovigilance
Lundbeck Foundation Personalised Medicine grant
Alexander Hauser receives HC Ørsted research talent prize
Artificial Intelligence in Pharmacoepidemiology: A Systematic Review. Part 1—Overview of Knowledge Discovery Techniques in Artificial Intelligence
Predictors of quetiapine extended‐release formulation add‐on in older patients exposed to antidepressant drugs: A Danish register‐based cohort study
The risk of fractures, acute myocardial infarction, atrial fibrillation and ventricular arrhythmia in geriatric patients exposed to promethazine
Metoprolol Versus Carvedilol in Patients With Heart Failure, Chronic Obstructive Pulmonary Disease, Diabetes Mellitus, and Renal Failure
Pharmacogenomics of GPCR Drug Targets
Evaluation of Generic versus Original Prostaglandin Analogues in the Treatment of Glaucoma: A Systematic Review and Meta-Analysis
Efficacy and Safety Evaluation of Benzalkonium Chloride Preserved Eye Drops Compared to Alternatively Preserved and Preservative-Free Eye Drops in the Treatment of Glaucoma: A Systematic Review and Data Analysis
Lactate: More Than Merely a Metabolic Waste Product in the Inner Retina
Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)
Increased Antioxidant Capacity and Pro-Homeostatic Lipid Mediators in Ocular Hypertension-A Human Experimental Model
Heterozygous Mutation (Q459R) in the Calcium-Sensing Receptor Gene Causes Familial Hypocalciuric Hypercalcemia 1 (FHH1)

Collaborators

Research projects

Animal models and patient studies to decipher the causes of glaucoma and improve glaucoma care.

Cancer-induced lysosomal changes promoting invasion and metastasis

Advancing personalised medicine for psychiatric diseases through integrative GPCR Pharmacogenomics

Pharmacometrics-based clustering for Pharmacoepidemiological risk stratification in real-world evidence for drugs with a narrow therapeutic index: a data science approach

Cluster Leader

Miriam Kolko
Professor MSO
miriamk@sund.ku.dk

Communications Representative

Alexander Hauser
Postdoc
alexander.hauser@sund.ku.dk

Members

Name	Title	Image
Alexander Sebastian Hauser	Postdoc
Flemming Steen Jørgensen	Professor
Hans Bräuner-Osborne	Professor
José Moreira	Professor
Lotte Stig Nørgaard	Associate Professor
Miriam Kolko	Professor with special responsibilities
Morten Andersen	Professor
Trine Meldgaard Lund	Associate Professor
Tuula Anneli Kallunki	Associate Professor